Essential medicines and pharmaceutical policies | Events and meetings | Good Governance for Medicines Programme, 2–3 March 2011

Good Governance for Medicines Programme, 2–3 March 2011

Print PDF

This activity was a follow up to the training on WHO methodology for assessing transparency and vulnerability to corruption in the pharmaceutical sector which took place in WHO Regional Office from 13 to 15 December 2010. The Good Governance for Medicines (GGM) programme team from the Regional Office introduced the GGM programme to Egyptian national co-assessors who will be conducting interviews with key informants in the Egyptian pharmaceutical sector.

The GGM programme supports participating countries to increase transparency and accountability in the regulation and supply of medicines. The assessment focuses on eight functions of the pharmaceutical chain: registration of medicines; licensing of pharmaceutical business; inspection of establishments; medicine promotion; clinical trials; selection of essential medicines; procurement of medicines; and distribution of medicines.

Two independent national assessors were cleared by the Ministry of Health and supported by WHO to conduct the assessment in 2011. The event discussed implementation of an Egyptian action plan for operationalizing the GGM study. Results of the study will assist officials and stakeholders of the sector in developing the pharmaceutical system relying on evidence-based decision and policy-making.

Related link

Good Governance for Medicines programme

Statistics and figures

Regional Health Observatory

Average pharmaceutical expenditure: US$ 1141 million

Average pharmaceutical expenditure per capita: US$ 57 

Average density of pharmacists: 5.02 per 10 000 population

Average number of licensed pharmaceutical manufacturers: 52

Average number of registered pharmaceutical products: 7529